These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 33838258

  • 1. Cannabinoid 2 receptors regulate dopamine 2 receptor expression by a beta-arrestin 2 and GRK5-dependent mechanism in neuronal cells.
    Franklin JM, Broseguini de Souza RK, Carrasco GA.
    Neurosci Lett; 2021 May 14; 753():135883. PubMed ID: 33838258
    [Abstract] [Full Text] [Related]

  • 2. G-protein receptor kinase 5 regulates the cannabinoid receptor 2-induced up-regulation of serotonin 2A receptors.
    Franklin JM, Carrasco GA.
    J Biol Chem; 2013 May 31; 288(22):15712-24. PubMed ID: 23592773
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling.
    Franklin JM, Carrasco GA.
    Synapse; 2013 Mar 31; 67(3):145-59. PubMed ID: 23151877
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. D2 autoreceptor switches CB2 receptor effects on [3 H]-dopamine release in the striatum.
    López-Ramírez G, Sánchez-Zavaleta R, Ávalos-Fuentes A, José Sierra J, Paz-Bermúdez F, Leyva-Gómez G, Segovia Vila J, Cortés H, Florán B.
    Synapse; 2020 Mar 31; 74(3):e22139. PubMed ID: 31610050
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bidirectional allosteric interactions between cannabinoid receptor 1 (CB1) and dopamine receptor 2 long (D2L) heterotetramers.
    Bagher AM, Laprairie RB, Toguri JT, Kelly MEM, Denovan-Wright EM.
    Eur J Pharmacol; 2017 Oct 15; 813():66-83. PubMed ID: 28734930
    [Abstract] [Full Text] [Related]

  • 11. Sequestration of dopamine D2 receptors depends on coexpression of G-protein-coupled receptor kinases 2 or 5.
    Ito K, Haga T, Lameh J, Sadée W.
    Eur J Biochem; 1999 Feb 15; 260(1):112-9. PubMed ID: 10091590
    [Abstract] [Full Text] [Related]

  • 12. Activation of cannabinoid receptor 2 inhibits experimental cystitis.
    Wang ZY, Wang P, Bjorling DE.
    Am J Physiol Regul Integr Comp Physiol; 2013 May 15; 304(10):R846-53. PubMed ID: 23515618
    [Abstract] [Full Text] [Related]

  • 13. Cannabinoids Stimulate the TRP Channel-Dependent Release of Both Serotonin and Dopamine to Modulate Behavior in C. elegans.
    Oakes M, Law WJ, Komuniecki R.
    J Neurosci; 2019 May 22; 39(21):4142-4152. PubMed ID: 30886012
    [Abstract] [Full Text] [Related]

  • 14. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling.
    Molina-Holgado E, Vela JM, Arévalo-Martín A, Almazán G, Molina-Holgado F, Borrell J, Guaza C.
    J Neurosci; 2002 Nov 15; 22(22):9742-53. PubMed ID: 12427829
    [Abstract] [Full Text] [Related]

  • 15. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor.
    Glass M, Felder CC.
    J Neurosci; 1997 Jul 15; 17(14):5327-33. PubMed ID: 9204917
    [Abstract] [Full Text] [Related]

  • 16. Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile.
    Gómez-Cañas M, Morales P, García-Toscano L, Navarrete C, Muñoz E, Jagerovic N, Fernández-Ruiz J, García-Arencibia M, Pazos MR.
    Pharmacol Res; 2016 Aug 15; 110():205-215. PubMed ID: 27013280
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors.
    Navarro G, Varani K, Lillo A, Vincenzi F, Rivas-Santisteban R, Raïch I, Reyes-Resina I, Ferreiro-Vera C, Borea PA, Sánchez de Medina V, Nadal X, Franco R.
    Pharmacol Res; 2020 Sep 15; 159():104940. PubMed ID: 32470563
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.